Moderna ​reiterated its previous statement that there were no new or undisclosed safety concerns in children or in pregnant ...

Pfizer will cut over 200 jobs in Switzerland as part of its multi-year cost reduction program, Bloomberg News reported on ...

Pfizer said on Tuesday it entered into an exclusive licensing agreement with YaoPharma, a subsidiary of China's Shanghai ...

A chemotherapy-free-based regimen of the TKI ponatinib combined with targeted immunotherapy showed significant benefits in ...

Fosun Pharmaceutical is a spinoff from Fosun International, which is chaired by China billionaire chairman Guo Guangchang; ...

Pfizer has rolled out detailed trial data suggesting Tukysa could be part of a new first-line treatment to delay the progression of HER2-positive breast cancer. | Pfizer has rolled out detailed trial ...

Pfizer’s RIF and severance practices face scrutiny in a Dec. 8 New Jersey filing by a former physician challenging OWBPA ...

With $6 billion left in firepower, Pfizer is planning transactions in the hundreds of millions to the low-billions range, ...

Pfizer Inc. (NYSE: PFE) is one of the best pharma stocks to invest in . Pfizer Inc. (NYSE:PFE) announced on December 6 ...

Pfizer Australia and BioNTech have welcomed the TGA's move to register the companies' new COVID-19 vaccine into its public ...

The Ghana Medical Trust Fund (GMTF) is initiating steps to get the right medication at the right time for Ghanaians. It will ...

Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.